# Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease

> **NCT00007033** · NA · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 25 (—)

## Conditions studied

- Alagille Syndrome
- Cholestasis
- Biliary Atresia

## Interventions

- **DRUG:** magnesium gluconate
- **DRUG:** magnesium sulfate

## Key facts

- **NCT ID:** NCT00007033
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 25 (—)
- **Last updated:** 2009-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00007033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00007033, "Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00007033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*